Patient adherence

Low patient adherence and unmanaged side effects pose a significant problem for healthcare systems the world over. How do you ensure patients take their medicine in the right way, at the right time, time after time? How do you identify potential side effects and instruct patients early enough to avoid treatment issues? Mass has developed patient adherence programmes for a number of orphan drugs which have seen good success in overcoming barriers to compliance.

These programmes combine patient education and adherence support tools with a personalised nurse support service. This multidiscipline approach helps empower patients with the knowledge of why they should stick to their prescribed treatment, and the belief in their ability to take control of their health. Enhanced patient adherence is good news all round, as optimal patient outcomes, improved physician-patient communication, and more cost-effective care benefits both patients and clinicians: fostering brand loyalty for the drug.

Back
Projects
Contact

“We organise into dynamic teams applying exactly the skills required to optimise resources and achieve results”

David Goodman, Managing Director

Contact
Portfolio

Physical, digital, social

Looking for a communications agency that covers all the bases? You have come to the right people. Mass knows just how to devise and implement a comprehensive, multichannel communications plan that’s exactly on spec and delivers the ideal, fully-integrated mix of physical, digital and social media.

More
Portfolio
Contact

Patient pathways

Mass are experts at helping health and wellness companies get their products to patients. We pioneer the latest tools to locate and access target CCGs, map individual patient pathways and provide valuable insights so brands can find and exploit new business opportunities. See how Mass helps healthcare brands take the path to success…


Portfolio
Contact

MSL optimisation and insights

As the complexity of products increases and the time shortens for launch there is increased pressure for MSLs to supply a deepened clinician interface, specific data provision and high science fluency, all of which are increasingly influential on product success.

More
Portfolio
Contact